A new technique for treating polycystic kidney disease has been identified by researchers at The University of Manchester and UCL. Published in the Journal of the American Society of Nephrology, the ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

"These included polycystic kidney disease ... implications for how CKD is diagnosed and managed in adults. "When the primary disease underlying a case of CKD is unknown, genetic analysis could ...

ADPKD, or autosomal dominant polycystic kidney disease, can cause severe pain, headaches, and more problems. What can you do to feel better and stay active? Find exercise and diet tips ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The team, led by Erik Larson, PhD, published results explaining how Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused, a common kidney disease considered incurable. ADPKD is lethal ...

An evidence-based kidney care app has secured £610,000 in seed funding, including a sizeable contribution from charity Kidney ...

Teams of researchers are investigating empagliflozin and dapagliflozin in patients with autosomal dominant polycystic kidney disease (AD PKD).

It affects more than 1 in 7 adults (14%) in the United States ... on underlying diseases that cause CKD, such as polycystic kidney disease or Alport syndrome, are also available.